Enhanced recovery after surgery for microsurgical oblique lateral interbody fusion

This study evaluates the real-world effectiveness and safety of a standardized enhanced recovery after surgery (ERAS) pathway in patients undergoing single-level microsurgical oblique lateral interbody fusion (MIS-OLIF) for lumbar degenerative disease. This retrospective before-and-after cohort study included 89 patients who underwent single-level MIS-OLIF at L3-4 or L4-5 between January 2021 and December 2023. Patients were categorized according to the institutional perioperative pathway in effect at the time of surgery: conventional care (n = 44) or ERAS (n = 45). The primary outcome was postoperative length of stay. Secondary outcomes included back-pain and leg-pain visual analog scale (VAS) scores, Oswestry Disability Index (ODI), ERAS-component adherence, discharge readiness, complications, readmission, and patient satisfaction. Selection bias was addressed using propensity-score overlap weighting, and repeated VAS and ODI measurements were analyzed using linear mixed-effects models. The ERAS group had a shorter unadjusted hospital stay than the conventional-care group (6.2 ± 0.8 vs 7.5 ± 1.2 days). After overlap-weighting adjustment, ERAS was associated with an adjusted reduction in postoperative length of stay of −1.1 days (95% confidence interval [CI]: −1.4 to −0.8; P < .001). Early postoperative back and leg pain were significantly lower in the ERAS group (group-by-time interaction P = .02 and P = .04, respectively). Overall ERAS adherence was 94.7% (median). Complication rates were 11.1% vs 18.2% (adjusted odds ratio 0.52, 95% CI: 0.14–1.94, P = .33), and satisfaction rates (satisfied/very satisfied) were 97.8% vs 93.2% ( P = .36). In this single-center real-world cohort, implementation of a standardized ERAS pathway was associated with earlier discharge after single-level MIS-OLIF. The effects on pain, function, satisfaction, and safety should be interpreted according to the adjusted analyses and remain subject to residual confounding inherent in the retrospective before-and-after design.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2026-10-09
DOI
https://doi.org/10.1097/md.0000000000051016
Primary Topic
Enhanced Recovery After Surgery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhanced recovery after surgery for microsurgical oblique lateral interbody fusion

Xia Qin, Xinghui Xie, Lingyun Qiu, Jie Chen et al.
Medicine
Enhanced Recovery After Surgery
article

Enhanced recovery after surgery for microsurgical oblique lateral interbody fusion

Xia Qin, Xinghui Xie, Lingyun Qiu, Jie Chen, Huaxi Li
article en

Abstract

This study evaluates the real-world effectiveness and safety of a standardized enhanced recovery after surgery (ERAS) pathway in patients undergoing single-level microsurgical oblique lateral interbody fusion (MIS-OLIF) for lumbar degenerative disease. This retrospective before-and-after cohort study included 89 patients who underwent single-level MIS-OLIF at L3-4 or L4-5 between January 2021 and December 2023. Patients were categorized according to the institutional perioperative pathway in effect at the time of surgery: conventional care (n = 44) or ERAS (n = 45). The primary outcome was postoperative length of stay. Secondary outcomes included back-pain and leg-pain visual analog scale (VAS) scores, Oswestry Disability Index (ODI), ERAS-component adherence, discharge readiness, complications, readmission, and patient satisfaction. Selection bias was addressed using propensity-score overlap weighting, and repeated VAS and ODI measurements were analyzed using linear mixed-effects models. The ERAS group had a shorter unadjusted hospital stay than the conventional-care group (6.2 ± 0.8 vs 7.5 ± 1.2 days). After overlap-weighting adjustment, ERAS was associated with an adjusted reduction in postoperative length of stay of −1.1 days (95% confidence interval [CI]: −1.4 to −0.8; P < .001). Early postoperative back and leg pain were significantly lower in the ERAS group (group-by-time interaction P = .02 and P = .04, respectively). Overall ERAS adherence was 94.7% (median). Complication rates were 11.1% vs 18.2% (adjusted odds ratio 0.52, 95% CI: 0.14–1.94, P = .33), and satisfaction rates (satisfied/very satisfied) were 97.8% vs 93.2% ( P = .36). In this single-center real-world cohort, implementation of a standardized ERAS pathway was associated with earlier discharge after single-level MIS-OLIF. The effects on pain, function, satisfaction, and safety should be interpreted according to the adjusted analyses and remain subject to residual confounding inherent in the retrospective before-and-after design.

MedicineVol. 105(41)
Army Medical University (CN), Xinqiao Hospital (CN)
Openalex Percentile: Top 10%
Enhanced Recovery After Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.